Doctor profile · Federal record

Dr. Emilia Popa, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Specialist · Dallas, TX

  • NPI 1952368045
  • Accepts Medicare
  • 41 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
9101 N Central Expy, Suite 350
Dallas, TX 752315927
(469) 800-7101
fax (214) 696-1502

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
August 24, 2016
Year of graduation
1985 — 41 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
Texas #L3071
Medicaid
TX #158390801

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1952368045. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
265
Distinct HCPCS
4
Medicare allowed
$29,514
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 157 120 $126
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 42 28 $34
99213 Established patient office or other outpatient visit, 20-29 minutes 39 34 $89
99215 Established patient office or other outpatient visit, 40-54 minutes 27 24 $179

In context: peer comparison

Among 30 peers in Dallas Endocrinology, Diabetes & Metabolism Physician, average services per provider: 142. This provider delivers 1.9× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$431
Transactions
26
Manufacturers
14
Payer (manufacturer) Industry Txns Amount
Lilly USA, LLC 4 $73.81
Amgen INC. 3 $47.94
Radius Health, INC. 3 $46.91
Tandem Diabetes Care, INC. 2 $46.70
Novo Nordisk INC 3 $42.28
Boehringer Ingelheim Pharmaceuticals, INC. 2 $34.84
Corcept Therapeutics 2 $29.16
Amneal Pharmaceuticals LLC 1 $27.48
Dexcom, INC. 1 $17.46
Medtronic, INC. 1 $15.22
Pfizer INC. 1 $14.72
Sanofi-Aventis U.S. LLC 1 $14.71
Mannkind Corporation 1 $13.37
CeQur Corporation 1 $6.21

By nature of payment

Food and Beverage
$431

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
993
Patients
270
Total drug cost
$332,296
Drug Type Claims Patients Total cost
Synthroid (Levothyroxine Sodium) Brand 202 41 $15,731
Levothyroxine Sodium Generic 189 55 $2,111
Ozempic (Semaglutide) Brand 91 26 $119,127
Metformin Hcl Generic 68 23 $801
Metformin Hcl ER (Metformin Hcl) Brand 58 21 $1,277
Novolog Flexpen (Insulin Aspart) Brand 49 17 $49,829
Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) Brand 43 16 $39,291
Atorvastatin Calcium Generic 40 11 $573
Jardiance (Empagliflozin) Brand 39 11 $47,241
Mounjaro (Tirzepatide) Brand 38 12 $49,817

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Emilia Popa's medical specialty?
Dr. Emilia Popa practices Endocrinology, Diabetes & Metabolism Physician in Dallas, TX.
Where does Dr. Emilia Popa practice?
Dr. Emilia Popa practices at 9101 N Central Expy, Dallas, TX 752315927. Office phone: 4698007101.
What is Dr. Emilia Popa's NPI?
Dr. Emilia Popa's National Provider Identifier (NPI) is 1952368045, issued by NPPES.
Does Dr. Emilia Popa accept Medicare assignment?
Yes. Dr. Emilia Popa accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Emilia Popa commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.